Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Breast Neoplasms 112 Neoplasms 73 Carcinoma, Non-Small-Cell Lung 36 Carcinoma, Renal Cell 35 Prostatic Neoplasms 34 Colorectal Neoplasms 34 Lung Neoplasms 31 Melanoma 17 Multiple Myeloma 15 Ovarian Neoplasms 13 Urinary Bladder Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasm Metastasis 11 Lymphoma, Follicular 11 Colonic Neoplasms 11 Stomach Neoplasms 10 Lymphoma 10 Kidney Neoplasms 10 Hematologic Neoplasms 10 Rectal Neoplasms 9 Arthritis, Rheumatoid 9 Recurrence 8 Papillomavirus Infections 8 Leukemia, Myeloid, Acute 8 Carcinoma, Hepatocellular 8 Pancreatic Neoplasms 7 Neoplasms, Plasma Cell 7 Lymphoma, Large B-Cell, Diffuse 7 COVID-19 7 Leukemia, Lymphocytic, Chronic, B-Cell 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Has results × Breakthrough Pain × Clear all

NCT00994760 2012-09-27

GENISIS

Takeda

131 enrolled 33 charts

Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡